These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 12605973

  • 1. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.
    Zelefsky MJ, Yamada Y, Marion C, Sim S, Cohen G, Ben-Porat L, Silvern D, Zaider M.
    Int J Radiat Oncol Biol Phys; 2003 Mar 15; 55(4):956-63. PubMed ID: 12605973
    [Abstract] [Full Text] [Related]

  • 2. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.
    Zelefsky MJ, Yamada Y, Cohen G, Venkatraman ES, Fung AY, Furhang E, Silvern D, Zaider M.
    Int J Radiat Oncol Biol Phys; 2000 Sep 01; 48(2):601-8. PubMed ID: 10974481
    [Abstract] [Full Text] [Related]

  • 3. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A, Chen H, Grebler A, Geltzeiler J, Geltzeiler M, Keselman I, Litvin S, Sim S, Hanlon A, Yang J.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1631-8. PubMed ID: 15590195
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
    Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, Grann A, Gaudin P, Fuks Z, Leibel SA.
    J Clin Oncol; 1999 Feb 01; 17(2):517-22. PubMed ID: 10080594
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ, Cohen G, Zakian KL, Dyke J, Koutcher JA, Hricak H, Schwartz L, Zaider M.
    Cancer J; 2000 Feb 01; 6(4):249-55. PubMed ID: 11038145
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.
    Brachytherapy; 2008 Feb 01; 7(1):1-6. PubMed ID: 18299108
    [Abstract] [Full Text] [Related]

  • 9. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.
    Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE.
    Int J Radiat Oncol Biol Phys; 2000 Jul 15; 47(5):1261-6. PubMed ID: 10889379
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation.
    Brown D, Colonias A, Miller R, Benoit R, Cohen J, Arshoun Y, Galloway M, Karlovits S, Wu A, Johnson M, Quinn A, Kalnicki S.
    Int J Radiat Oncol Biol Phys; 2000 May 01; 47(2):353-60. PubMed ID: 10802359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):664-73. PubMed ID: 11849788
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.
    King MT, Nasser NJ, Mathur N, Cohen GN, Kollmeier MA, Yuen J, Vargas HA, Pei X, Yamada Y, Zakian KL, Zaider M, Zelefsky MJ.
    Brachytherapy; 2016 Mar 01; 15(3):266-273. PubMed ID: 27009848
    [Abstract] [Full Text] [Related]

  • 16. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA, Kestin LL, Martinez AA.
    Tech Urol; 2000 Jun 01; 6(2):135-45. PubMed ID: 10798815
    [Abstract] [Full Text] [Related]

  • 17. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
    Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S.
    Int J Radiat Oncol Biol Phys; 1999 Aug 01; 45(1):59-67. PubMed ID: 10477007
    [Abstract] [Full Text] [Related]

  • 18. Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer.
    Singh A, Zelefsky MJ, Raben A, Lombardi D, Leibel SA.
    Int J Cancer; 2000 Oct 20; 90(5):275-80. PubMed ID: 11091351
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Review on the effectiveness of prostate cancer brachytherapy].
    Inciūra A, Jarusevicus L, Vaiciūnas K, Juozaityte E.
    Medicina (Kaunas); 2009 Oct 20; 45(8):660-71. PubMed ID: 19773626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.